2019 agenda

Thursday, January 31, 2019

6:45 7:45 Breakfast- Frontenac Ballroom C
7:45 8:00 SHOW Welcome – SHOW Chairs- Frontenac Ballroom A & B
8:00 8:15 MSI in mCRC: Pathology Perspectives – Dr. Celia Marginean
8:20 8:35 Update on Clinical Management of mCRC: Right Sided Primary, Immune Therapy and other Flavors of the Week – Dr. Jonathan Loree
8:40 8:55 Liquid Biopsy: State of the Union – Dr. Mike Overman
9:00 9:15 SHOW Case -Introduction  –  Moderator: Dr. David Liu
9:20 9:35 Management of Colorectal Cancer with Synchronous Liver Metastases – Dr. Sean Cleary
9:40 9:55 Ablation: Margins and Markers – Dr. Constantinos Sofocleous
10:00 10:15 BREAK & Visit with Sponsors – Frontenac Foyer
10:20 10:35 Risk and Epidemiology of VTE in Cancer Patients – Dr. Marc Carrier
10:40 10:55 Surgical and Endovascular Management of DVT & PE in the Cancer Patient – Dr. Nicholas Fidelman
11:00 11:15 Long Term Management and Thrombosis in the Cancer Patient – Dr. Marc Carrier
11:20 11:55 PANEL Discussion: CAT & Cancer
Moderator: Dr. David Liu  –  Panel: Drs. Carrier, Fidelman, Hansen & Srinivas
12:00 13:15 LUNCH Keynote Speaker -Dr. Joseph Amaral  –   Frontenac Ballroom C
13:20 13:35 Pushing the Limits of Resection: Balancing the Technical Advances and Tumour Biology – Dr. Ian McGilvray
13:40 13:55 Resect, Ablate, Irradiate or Radioembolize? – Dr. Constantinos Sofocleous
14:00 14:15 This Is Not Your Parents PET: PET Imaging Update – Dr. Shyam Srinivas
14:20 14:55 PANEL Discussion: mCRC Biomarkers and Decision Making
Moderator: Dr. Paul Hansen  –  Panel: Drs. McGilvray, Marginean, Overman & Sofocleous
15:00 15:15 BREAK & Visit with Sponsors –  Frontenac Foyer
15:20 15:55 SHOW Case Discussion
Moderator: Dr. David Liu  –  Panel: Drs. Carrier, Dawson, Fidelman & Lim
16:00 16:15 Closing Remarks
16:15 18:15 Welcome Reception and Visit with Sponsors – Frontenac Foyer

Friday, February 1, 2019

6:45 7:45 Breakfast- Frontenac Ballroom C
7:45 8:00 Welcome & Introductions- SHOW Chairs –  Frontenac Ballroom A & B
8:00 8:15 Dosimetric Decision Making: Upstream and Downstream Considerations – Dr. Andrew Kennedy
8:20 8:35 PPRT: Net and Beyond – Dr. Shyam Srinivas
8:40 8:55 Dose Modulation and Response in Y90 SBRT and Chemotherapy – Dr. Andrew Kennedy
9:00 9:15 The Role of Liver Directed Therapy in NET – Dr. Nicholas Fidelman
9:20 9:35 SHOW Case – Introduction
Moderator: Dr. Peter Kim
9:40 9:55 BREAK & Visit with Sponsors – Frontenac Foyer
10:00 10:15 Update on Systemic Therapies for HCC: 2nd Line Prime Time – Dr. Howard Lim
10:20 10:35 Sequencing of Locoregional Therapy in HCC – Dr. Laura Dawson
10:40 10:55 Perspectives on Embolotherapy and HCC: Combining Guidelines and Grit – Dr. Howard Lim
11:00 11:35 PANEL Discussion:  HCC w/ PVT and Extrahepatic Disease
Moderator: Dr. Peter Kim  –  Panel: Drs. Dawson, Fidelman, Lim & McGilvray
11:40 13:15 LUNCH – Frontenac Ballroom C
13:20 13:35 Overview of the Approach to Extrahepatic Cholangiocarcinoma: Clinical Staging, Determining Resectability – Dr. Sean Cleary
13:40 13:55 Liver Transplant: Update on Hilar Cholangiocarcinoma, CRM, NET and ICC – Dr. Peter Kim
14:00 14:15 Overwhelming Tumor Physiology: Optimizing Embolization Techniques – Dr. Darren Klass
14:20 14:35 The Era of IO: Immuno-oncology – Dr. Mike Overman
14:40 14:55 SBRT for HCC, CCA and mCRC Update – Dr. Laura Dawson
15:00 15:15 BREAK & Visit with Sponsors  – Frontenac Foyer
15:20 15:55 SHOW Case Discussion
Moderator: Dr. Peter Kim  –  Panel: Drs. Amaral, Cleary, Kennedy & Srinivas
16:00 16:15 Closing  Remarks